Bayesian Capital Management’s TransAlta TAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,570
Closed -$110K 1030
2024
Q2
$110K Sell
15,570
-7,000
-31% -$47.9K 0.01% 647
2024
Q1
$145K Buy
22,570
+11,600
+106% +$82.3K 0.01% 686
2023
Q4
$91.2K Buy
+10,970
New +$88.6K 0.01% 660
2023
Q2
Sell
-11,621
Closed -$102K 1053
2023
Q1
$102K Sell
11,621
-8,455
-42% -$74.5K 0.01% 685
2022
Q4
$180K Buy
+20,076
New +$180K 0.03% 614
2020
Q2
Sell
-12,316
Closed -$65K 773
2020
Q1
$65K Buy
+12,316
New +$83.5K 0.01% 707

Other funds holding TAC

Bayesian Capital Management's TAC Position: Q3 2024 in Review

Bayesian Capital Management sold out of TransAlta (TAC) in Q3 2024, closing a stake of 15,570 shares — an estimated $110K sold.

Bayesian Capital Management first reported a position in TAC in Q1 2020 and held it in 6 quarters. The position peaked at $180K in Q4 2022. 156 funds tracked by Wall St. Rank hold TAC as of Q3 2024.

  • Bayesian Capital Management reported no remaining TransAlta position as of Q3 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 15,570 TransAlta shares in Q3 2024, an estimated $110K.
  • Bayesian Capital Management first reported a position in TransAlta in Q1 2020 and held it in 6 quarters.
  • Bayesian Capital Management's TransAlta position peaked at $180K in Q4 2022.
  • 156 funds tracked by Wall St. Rank held TransAlta as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.